64
views
0
recommends
+1 Recommend
0 collections
    4
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Seroprevalence of Trichodysplasia Spinulosa–associated Polyomavirus

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We identified a new polyomavirus in skin lesions from a patient with trichodysplasia spinulosa (TS). Apart from TS being an extremely rare disease, little is known of its epidemiology. On the basis of knowledge regarding other polyomaviruses, we anticipated that infections with trichodysplasia spinulosa–associated polyomavirus (TSV) occur frequently and become symptomatic only in immunocompromised patients. To investigate this hypothesis, we developed and used a Luminex-based TSV viral protein 1 immunoassay, excluded cross-reactivity with phylogenetically related Merkel cell polyomavirus, and measured TSV seroreactivity. Highest reactivity was found in a TS patient. In 528 healthy persons in the Netherlands, a wide range of seroreactivities was measured and resulted in an overall TSV seroprevalence of 70% (range 10% in small children to 80% in adults). In 80 renal transplant patients, seroprevalence was 89%. Infection with the new TSV polyomavirus is common and occurs primarily at a young age.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins.

          More than 100 different human papillomaviruses (HPVs) can cause proliferative diseases, many of which are malignant, such as cervical cancer. HPV serology is complex because infection and disease lead to distinct type-specific antibody responses. Using bead-based technology, we have developed an assay platform that allows the simultaneous detection of antibodies against up to 100 in situ affinity-purified recombinant HPV proteins. Twenty-seven HPV proteins were expressed as glutathione S-transferase fusion proteins and affinity-purified in one step by incubation of glutathione-displaying beads in bacterial lysate. Spectrally distinct bead sets, each carrying one particular antigen, were mixed, incubated with serum, and differentiated in a flow cytometer-like analyzer (xMAP; Luminex Corp). Antibodies bound to the antigens were detected via fluorescent secondary reagents. We studied 756 sera from 2 case-control studies of cervical cancer. Glutathione S-transferase fusion proteins bound with high affinity to glutathione-displaying beads (Kd = 6.9 x 10(-9) mol/L). The dynamic range of multiplex serology covered 1.5 orders of magnitude, and antibodies were detected at serum dilutions >1:1,000,000. Imprecision (median CV) was < or = 5.4%, and assay reproducibility was high (R2 = 0.97). Results on clinical samples showed high concordance with ELISA (kappa = 0.846), but multiplex serology exhibited increased detection of weak antibody responses. Antibodies to the E6 oncoproteins of the rare HPV types 52 and 58 were associated with cervical cancer (P < 0.001). Multiplex serology enables antibody analyses of large numbers of sera against up to 100 antigens in parallel and has the potential to replace ELISA technology.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            New human papovavirus (B.K.) isolated from urine after renal transplantation.

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy.

                Bookmark

                Author and article information

                Journal
                Emerg Infect Dis
                Emerging Infect. Dis
                EID
                Emerging Infectious Diseases
                Centers for Disease Control and Prevention
                1080-6040
                1080-6059
                August 2011
                : 17
                : 8
                : 1355-1363
                Affiliations
                [1]Author affiliations: Leiden University Medical Center, Leiden, the Netherlands (E. van der Meijden, S. Kazem, M.M. Burgers, J.N. Bouwes Bavinck, M.C.W. Feltkamp);
                [2]Jeroen Bosch Ziekenhuis, ‘s Hertogenbosch, the Netherlands (R. Janssens);
                [3]National Institute of Public Health and the Environment, Bilthoven, the Netherlands (H. de Melker)
                Author notes
                Address for correspondence: Els van der Meijden, Department of Medical Microbiology E4-P, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, the Netherlands; email: p.z.van_der_meijden@ 123456lumc.nl
                Article
                11-0114
                10.3201/eid1708.110114
                3381547
                21801610
                0a52c08f-9dc5-49a9-93f3-0ea636bfeb63
                History
                Categories
                Research

                Infectious disease & Microbiology
                seroprevalence,viruses,polyomavirus,immunoassay,research,the netherlands,trichodysplasia spinulosa,trichodysplasia spinulosa–associated virus,epidemiology,immunocompromised host

                Comments

                Comment on this article